Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion

Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 do...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 1994-05, Vol.127 (5), p.1201-1211
Hauptverfasser: Nichols, W.W., Nicolini, F.A., Yang, B.C., Henson, K., Stechmiller, J.K., Mehta, J.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1211
container_issue 5
container_start_page 1201
container_title The American heart journal
container_volume 127
creator Nichols, W.W.
Nicolini, F.A.
Yang, B.C.
Henson, K.
Stechmiller, J.K.
Mehta, J.L.
description Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 dogs to total left anterior descending (LAD) coronary artery occlusion (1 hour) and reperfusion (1 hour). Seven dogs received adenosine (3.75 mg/min into the LAD distal to the occlusion) over a 1-hour period starting 5 minutes before reperfusion, and the remaining seven dogs received saline solution. One dog in each group died of ventricular fibrillation during coronary artery occlusion. Coronary flow reserve, measured as peak reactive hyperemia (10 and 20 seconds of total coronary artery occlusion) and peak coronary blood flow response to acetylcholine (0.01 to 1.0 μg) and nitroglycerin (5 to 25 μg), was impaired in the LAD region after LAD occlusion and reperfusion in the saline-treated dogs (all p < 0.01 vs before occlusion and reperfusion); LAD regional myocardial shortening fraction measured by ultrasonic crystals was also diminished after occlusion and reperfusion in saline-treated dogs (−5% ± 1% vs 12% ± 2%; p < 0.02). The adenosine-treated dogs showed total protection against loss of coronary flow reserve (peak reactive hyperemia and blood flow increase in response to acetylcholine and nitroglycerin; all p values not significant vs before LAD occlusion and reperfusion). LAD regional myocardial shortening fraction was also preserved in adenosine-treated dogs (9% ± 2% vs 14% ± 2%; p not significant). Myocardial myeloperoxidase activity, measured as an index of myocardial leukocyte infiltration, was greater ( p < 0.02) in the LAD ischemic-reperfused regions than in nonischemic circumflex regions in the saline-treated dogs. A similar difference in myeloperoxidase activities in the reperfused and control regions was not observed in the adenosine-treated dogs. Thus adenosine protects against loss of coronary flow reserve and regional myocardial function in dogs subjected to coronary artery occlusion and reperfusion.
doi_str_mv 10.1016/0002-8703(94)90037-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76469874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000287039490037X</els_id><sourcerecordid>76469874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-f1c6a42b798671c67713934311d2be60634f89bef7d3487875761f3ca2b19c183</originalsourceid><addsrcrecordid>eNp9kUlrHDEQhUVIsMfLP4hBh2DsQydSS9ZyMRjjDQy5JOCbUKtLQaFHmkhqG_97axbmmJNUvO8VVa8Q-krJd0qo-EEI6TslCbvQ_FITwmT38gktKNGyE5Lzz2ixRw7RUSl_Wyl6JQ7QgaKyJ1wu0NvNCDGVEAGvcqrgasH2jw2xVGxrhTjbGlLEyWM_pTecoUB-BWzjiJfvydk8BjthP0e34ayvkLFLOUWb33FybprLRmiGDCvIflOfoC_eTgVOd-8x-n1_9-v2sXv--fB0e_PcOaZE7Tx1wvJ-kFoJ2f5SUqYZZ5SO_QCCCMa90gN4OTKupJJXUlDPnO0Hqh1V7Bidb_u27f7NUKpZhuJgmmyENBcjBRdaSd5AvgVdTqVk8GaVw7LtYCgx67zNOkyzDtNobjZ5m5dmO9v1n4cljHvTLuCmf9vptjg7-WyjC2WPccqu2swNu95i0LJ4DZBNcQGigzHkdhMzpvD_OT4Ae4id8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76469874</pqid></control><display><type>article</type><title>Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Nichols, W.W. ; Nicolini, F.A. ; Yang, B.C. ; Henson, K. ; Stechmiller, J.K. ; Mehta, J.L.</creator><creatorcontrib>Nichols, W.W. ; Nicolini, F.A. ; Yang, B.C. ; Henson, K. ; Stechmiller, J.K. ; Mehta, J.L.</creatorcontrib><description>Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 dogs to total left anterior descending (LAD) coronary artery occlusion (1 hour) and reperfusion (1 hour). Seven dogs received adenosine (3.75 mg/min into the LAD distal to the occlusion) over a 1-hour period starting 5 minutes before reperfusion, and the remaining seven dogs received saline solution. One dog in each group died of ventricular fibrillation during coronary artery occlusion. Coronary flow reserve, measured as peak reactive hyperemia (10 and 20 seconds of total coronary artery occlusion) and peak coronary blood flow response to acetylcholine (0.01 to 1.0 μg) and nitroglycerin (5 to 25 μg), was impaired in the LAD region after LAD occlusion and reperfusion in the saline-treated dogs (all p &lt; 0.01 vs before occlusion and reperfusion); LAD regional myocardial shortening fraction measured by ultrasonic crystals was also diminished after occlusion and reperfusion in saline-treated dogs (−5% ± 1% vs 12% ± 2%; p &lt; 0.02). The adenosine-treated dogs showed total protection against loss of coronary flow reserve (peak reactive hyperemia and blood flow increase in response to acetylcholine and nitroglycerin; all p values not significant vs before LAD occlusion and reperfusion). LAD regional myocardial shortening fraction was also preserved in adenosine-treated dogs (9% ± 2% vs 14% ± 2%; p not significant). Myocardial myeloperoxidase activity, measured as an index of myocardial leukocyte infiltration, was greater ( p &lt; 0.02) in the LAD ischemic-reperfused regions than in nonischemic circumflex regions in the saline-treated dogs. A similar difference in myeloperoxidase activities in the reperfused and control regions was not observed in the adenosine-treated dogs. Thus adenosine protects against loss of coronary flow reserve and regional myocardial function in dogs subjected to coronary artery occlusion and reperfusion.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/0002-8703(94)90037-X</identifier><identifier>PMID: 8172047</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Acetylcholine - pharmacology ; Adenosine - administration &amp; dosage ; Adenosine - pharmacology ; Animals ; Antianginal agents. Coronary vasodilator agents ; Biological and medical sciences ; Cardiovascular system ; Coronary Circulation - drug effects ; Coronary Disease - physiopathology ; Coronary Vessels ; Dogs ; Female ; Heart - drug effects ; Heart - physiology ; Hemodynamics - drug effects ; Infusions, Intra-Arterial ; Male ; Medical sciences ; Myocardial Reperfusion Injury - physiopathology ; Myocardium - enzymology ; Nitroglycerin - pharmacology ; Peroxidase - analysis ; Peroxidase - drug effects ; Pharmacology. Drug treatments ; Random Allocation</subject><ispartof>The American heart journal, 1994-05, Vol.127 (5), p.1201-1211</ispartof><rights>1994</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-f1c6a42b798671c67713934311d2be60634f89bef7d3487875761f3ca2b19c183</citedby><cites>FETCH-LOGICAL-c386t-f1c6a42b798671c67713934311d2be60634f89bef7d3487875761f3ca2b19c183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/000287039490037X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4135757$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8172047$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nichols, W.W.</creatorcontrib><creatorcontrib>Nicolini, F.A.</creatorcontrib><creatorcontrib>Yang, B.C.</creatorcontrib><creatorcontrib>Henson, K.</creatorcontrib><creatorcontrib>Stechmiller, J.K.</creatorcontrib><creatorcontrib>Mehta, J.L.</creatorcontrib><title>Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 dogs to total left anterior descending (LAD) coronary artery occlusion (1 hour) and reperfusion (1 hour). Seven dogs received adenosine (3.75 mg/min into the LAD distal to the occlusion) over a 1-hour period starting 5 minutes before reperfusion, and the remaining seven dogs received saline solution. One dog in each group died of ventricular fibrillation during coronary artery occlusion. Coronary flow reserve, measured as peak reactive hyperemia (10 and 20 seconds of total coronary artery occlusion) and peak coronary blood flow response to acetylcholine (0.01 to 1.0 μg) and nitroglycerin (5 to 25 μg), was impaired in the LAD region after LAD occlusion and reperfusion in the saline-treated dogs (all p &lt; 0.01 vs before occlusion and reperfusion); LAD regional myocardial shortening fraction measured by ultrasonic crystals was also diminished after occlusion and reperfusion in saline-treated dogs (−5% ± 1% vs 12% ± 2%; p &lt; 0.02). The adenosine-treated dogs showed total protection against loss of coronary flow reserve (peak reactive hyperemia and blood flow increase in response to acetylcholine and nitroglycerin; all p values not significant vs before LAD occlusion and reperfusion). LAD regional myocardial shortening fraction was also preserved in adenosine-treated dogs (9% ± 2% vs 14% ± 2%; p not significant). Myocardial myeloperoxidase activity, measured as an index of myocardial leukocyte infiltration, was greater ( p &lt; 0.02) in the LAD ischemic-reperfused regions than in nonischemic circumflex regions in the saline-treated dogs. A similar difference in myeloperoxidase activities in the reperfused and control regions was not observed in the adenosine-treated dogs. Thus adenosine protects against loss of coronary flow reserve and regional myocardial function in dogs subjected to coronary artery occlusion and reperfusion.</description><subject>Acetylcholine - pharmacology</subject><subject>Adenosine - administration &amp; dosage</subject><subject>Adenosine - pharmacology</subject><subject>Animals</subject><subject>Antianginal agents. Coronary vasodilator agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Coronary Circulation - drug effects</subject><subject>Coronary Disease - physiopathology</subject><subject>Coronary Vessels</subject><subject>Dogs</subject><subject>Female</subject><subject>Heart - drug effects</subject><subject>Heart - physiology</subject><subject>Hemodynamics - drug effects</subject><subject>Infusions, Intra-Arterial</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Myocardial Reperfusion Injury - physiopathology</subject><subject>Myocardium - enzymology</subject><subject>Nitroglycerin - pharmacology</subject><subject>Peroxidase - analysis</subject><subject>Peroxidase - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Random Allocation</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUlrHDEQhUVIsMfLP4hBh2DsQydSS9ZyMRjjDQy5JOCbUKtLQaFHmkhqG_97axbmmJNUvO8VVa8Q-krJd0qo-EEI6TslCbvQ_FITwmT38gktKNGyE5Lzz2ixRw7RUSl_Wyl6JQ7QgaKyJ1wu0NvNCDGVEAGvcqrgasH2jw2xVGxrhTjbGlLEyWM_pTecoUB-BWzjiJfvydk8BjthP0e34ayvkLFLOUWb33FybprLRmiGDCvIflOfoC_eTgVOd-8x-n1_9-v2sXv--fB0e_PcOaZE7Tx1wvJ-kFoJ2f5SUqYZZ5SO_QCCCMa90gN4OTKupJJXUlDPnO0Hqh1V7Bidb_u27f7NUKpZhuJgmmyENBcjBRdaSd5AvgVdTqVk8GaVw7LtYCgx67zNOkyzDtNobjZ5m5dmO9v1n4cljHvTLuCmf9vptjg7-WyjC2WPccqu2swNu95i0LJ4DZBNcQGigzHkdhMzpvD_OT4Ae4id8w</recordid><startdate>19940501</startdate><enddate>19940501</enddate><creator>Nichols, W.W.</creator><creator>Nicolini, F.A.</creator><creator>Yang, B.C.</creator><creator>Henson, K.</creator><creator>Stechmiller, J.K.</creator><creator>Mehta, J.L.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940501</creationdate><title>Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion</title><author>Nichols, W.W. ; Nicolini, F.A. ; Yang, B.C. ; Henson, K. ; Stechmiller, J.K. ; Mehta, J.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-f1c6a42b798671c67713934311d2be60634f89bef7d3487875761f3ca2b19c183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Acetylcholine - pharmacology</topic><topic>Adenosine - administration &amp; dosage</topic><topic>Adenosine - pharmacology</topic><topic>Animals</topic><topic>Antianginal agents. Coronary vasodilator agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Coronary Circulation - drug effects</topic><topic>Coronary Disease - physiopathology</topic><topic>Coronary Vessels</topic><topic>Dogs</topic><topic>Female</topic><topic>Heart - drug effects</topic><topic>Heart - physiology</topic><topic>Hemodynamics - drug effects</topic><topic>Infusions, Intra-Arterial</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Myocardial Reperfusion Injury - physiopathology</topic><topic>Myocardium - enzymology</topic><topic>Nitroglycerin - pharmacology</topic><topic>Peroxidase - analysis</topic><topic>Peroxidase - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Random Allocation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nichols, W.W.</creatorcontrib><creatorcontrib>Nicolini, F.A.</creatorcontrib><creatorcontrib>Yang, B.C.</creatorcontrib><creatorcontrib>Henson, K.</creatorcontrib><creatorcontrib>Stechmiller, J.K.</creatorcontrib><creatorcontrib>Mehta, J.L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nichols, W.W.</au><au>Nicolini, F.A.</au><au>Yang, B.C.</au><au>Henson, K.</au><au>Stechmiller, J.K.</au><au>Mehta, J.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>1994-05-01</date><risdate>1994</risdate><volume>127</volume><issue>5</issue><spage>1201</spage><epage>1211</epage><pages>1201-1211</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Total coronary artery occlusion and reperfusion result in attenuation of coronary blood flow reserve, regional myocardial dysfunction, and myocardial leukocyte infiltration. To examine the effects of intracoronary adenosine on these occlusion and reperfusion-induced perturbations, we subjected 14 dogs to total left anterior descending (LAD) coronary artery occlusion (1 hour) and reperfusion (1 hour). Seven dogs received adenosine (3.75 mg/min into the LAD distal to the occlusion) over a 1-hour period starting 5 minutes before reperfusion, and the remaining seven dogs received saline solution. One dog in each group died of ventricular fibrillation during coronary artery occlusion. Coronary flow reserve, measured as peak reactive hyperemia (10 and 20 seconds of total coronary artery occlusion) and peak coronary blood flow response to acetylcholine (0.01 to 1.0 μg) and nitroglycerin (5 to 25 μg), was impaired in the LAD region after LAD occlusion and reperfusion in the saline-treated dogs (all p &lt; 0.01 vs before occlusion and reperfusion); LAD regional myocardial shortening fraction measured by ultrasonic crystals was also diminished after occlusion and reperfusion in saline-treated dogs (−5% ± 1% vs 12% ± 2%; p &lt; 0.02). The adenosine-treated dogs showed total protection against loss of coronary flow reserve (peak reactive hyperemia and blood flow increase in response to acetylcholine and nitroglycerin; all p values not significant vs before LAD occlusion and reperfusion). LAD regional myocardial shortening fraction was also preserved in adenosine-treated dogs (9% ± 2% vs 14% ± 2%; p not significant). Myocardial myeloperoxidase activity, measured as an index of myocardial leukocyte infiltration, was greater ( p &lt; 0.02) in the LAD ischemic-reperfused regions than in nonischemic circumflex regions in the saline-treated dogs. A similar difference in myeloperoxidase activities in the reperfused and control regions was not observed in the adenosine-treated dogs. Thus adenosine protects against loss of coronary flow reserve and regional myocardial function in dogs subjected to coronary artery occlusion and reperfusion.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>8172047</pmid><doi>10.1016/0002-8703(94)90037-X</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 1994-05, Vol.127 (5), p.1201-1211
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_miscellaneous_76469874
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetylcholine - pharmacology
Adenosine - administration & dosage
Adenosine - pharmacology
Animals
Antianginal agents. Coronary vasodilator agents
Biological and medical sciences
Cardiovascular system
Coronary Circulation - drug effects
Coronary Disease - physiopathology
Coronary Vessels
Dogs
Female
Heart - drug effects
Heart - physiology
Hemodynamics - drug effects
Infusions, Intra-Arterial
Male
Medical sciences
Myocardial Reperfusion Injury - physiopathology
Myocardium - enzymology
Nitroglycerin - pharmacology
Peroxidase - analysis
Peroxidase - drug effects
Pharmacology. Drug treatments
Random Allocation
title Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adenosine%20protects%20against%20attenuation%20of%20flow%20reserve%20and%20myocardial%20function%20after%20coronary%20occlusion%20and%20reperfusion&rft.jtitle=The%20American%20heart%20journal&rft.au=Nichols,%20W.W.&rft.date=1994-05-01&rft.volume=127&rft.issue=5&rft.spage=1201&rft.epage=1211&rft.pages=1201-1211&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/0002-8703(94)90037-X&rft_dat=%3Cproquest_cross%3E76469874%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76469874&rft_id=info:pmid/8172047&rft_els_id=000287039490037X&rfr_iscdi=true